Soluble receptor activator of nuclear factor-κB ligand (sRANKL)/osteoprotegerin balance in ageing and age-associated diseases

Biogerontology

Volumn 5, Issue 2, 2004, Pages 119-127

  Pulsatelli, Lia ^a   Dolzani, Paolo ^a   Silvestri, Tania ^a   Caraceni, Paolo ^b   Facchini, Andrea ^a,b   Ravaglia, Giovanni ^b   Salvarani, Carlo ^c   Meliconi, Riccardo ^b,d   Mariani, Erminia ^a,b  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Servizio di Reumatologia   (Italy)

^d Modulo di Reumatologia   (Italy)

Author keywords

Ageing; Osteoarthritis; Osteoprotegerin; Polymyalgia rheumatica; RANKL

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

AGED; AGING; ARTICLE; BONE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GERIATRIC DISORDER; HUMAN; IMMUNE SYSTEM; IMMUNOASSAY; KNEE OSTEOARTHRITIS; MALE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHEUMATIC POLYMYALGIA; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; AGING; CARRIER PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOASSAY; MALE; MEMBRANE GLYCOPROTEINS; OSTEOARTHRITIS; OSTEOPROTEGERIN; POLYMYALGIA RHEUMATICA; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; SEX FACTORS; STATISTICS;

EID: 4344718598     PISSN: 13895729     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BGEN.0000025075.04136.ec     Document Type: Article

References (43)

1. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, et al. (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29: 1039-1049
2. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, Brown C, Cooke TD, Daniel W, Feldman D, et al. (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34: 505-514
3. Altman RD, Hochberg M, Murphy WA Jr, Wolfe F and Lequesne M (1995) Atlas of individual radiographic features in osteoarthritis. Osteoarthritis Cartilage 3(suppl. A): 3-70
4. Arron JR and Choi Y (2000) Bone versus immune system. Nature 408: 535-536
5. Bailey AJ, Buckland-Wright C and Metz D (2001) The role of bone in osteoarthritis. Age Ageing 30: 374-378
6. Bekker PJ, Holloway D, Nakanishi A, Arrighi M, Leese PT and Dunstan CR (2001) The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res 16: 348-360
7. Boesen P and Sørensen SF (1987) Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish County: a prospective investigation, 1982-1985. Arthritis Rheum 30: 294-299
8. Cao J, Venton L, Sakata T and Halloran BP (2003) Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J Bone Miner Res 18: 270-277
9. Crotti TN, Smith MD, Weedon H, Ahern MJ, Findlay DM, Kraan M, Tak PP and Haynes DR (2002) Receptor activator NF-κB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. Ann Rheum Dis 61: 1047-1054
10. Dasgupta B and Panayi GS (1990) Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 29: 456-458
11. Dolan AL, Moniz C, Dasgupta B, Li F, MacKintosh C, Todd P, Corrigall V and Panayi GS (1997) Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica. Arthritis Rheum 40: 2022-2029
12. Doria G and Frasca D (1997) Genes, immunity, and senescence: looking for a link. Immunol Rev 160: 159-170
13. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL and Riggs BL (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111: 1221-1230
14. Fazzalari NL, Kuliwaba JS, Atkins GJ, Forwood MR and Findlay DM (2001) The ratio of messenger RNA levels of receptor activator of nuclear factor κB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. J Bone Miner Res 16: 1015-1027
15. Fernández-Gutiérrez B, Jover JA, De Miguel S, Hernández-García C, Vidán MT, Ribera JM, Bañares A and Serra JA (1999) Early lymphocyte activation in elderly humans: impaired T and T-dependent B cell responses. Exp Gerontol 34: 217-229
16. Haynes DR, Barg E, Crotti TN, Holding C, Weedon H, Atkins GJ, Zannetino A, Ahern MJ, Coleman M, Roberts-Thomson PJ, Kraan M, Tak PP and Smith MD (2003) Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Rheumatology 42: 123-134
17. Ikeda T, Utsuyama M and Hirokawa K (2001) Expression profiles of receptor activator of nuclear factor κB ligand, receptor activator of nuclear factor κB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. J Bone Miner Res 16: 1416-1425
18. Jones HD, Kong Y-Y and Penninger JM (2002) Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis 61(suppl. II): ii32-ii39
19. Jung K, Lein M, Hosslin K, Grosse A, Roth S, Possinger K and Luftner D (2002) Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in the serum of healthy adults. Int J Biol Markers 17: 177-181
20. Kawaguchi H, Manabe N, Chikuda H, Nakamura K and Kuro-o M (2000) Cellular and molecular mechanism of low-turnover osteopenia in the klotho-defficient mouse. Cell Mol Life Sci 57: 731-737
21. Khosla S (2001) Minireview: the OPG/RANKL/RANK system. Endocrinology 142: 5050-5055
22. Khosla S, Arrighi HM, Melton LJ, III, Atkinson EJ, O'Fallon WM, Dunstan C and Riggs BL (2002) Correlates of osteoprotegerin levels in women and men. Osteoporos Int 13: 394-399
23. Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, Muller-Hermelink HK and Steinmann GG (1984) Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 28: 47-55
24. Lorenzo J (2000) Interactions between immune and bone cells: new insights with many remaining questions. J Clin Invest 106:749-752
25. Macchioni P, Boiardi L, Meliconi R, Salvarani C, Uguccioni MG, Rossi F, Pulsatelli L and Facchini A (1994) Elevated soluble intercellular adhesion molecule 1 in the serum of patients with polymyalgia rheumatica: influence of steroid treatment. J Rheumatol 21: 1860-1864
26. Makhluf HA, Mueller SM, Mizuno S and Glowacki J (2000) Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges. Biochem Biophys Res Commun 268: 669-672
27. Meliconi R, Pulsatelli L, Dolzani P, Boiardi L, Macchioni P, Salvarani C, Silvestri T, Frizziero L and Facchini A (2000) Vascular endothelial growth factor production in polymyalgia rheumatica. Arthritis Rheum 43: 2472-2480
28. Miller RA (1996) The aging immune system: primer and prospectus. Science 273: 70-74
29. Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, Sato Y, Nakagawa N, Yasuda H, Mochizuki S, Gomibuchi T, Yano K, Shima N, Washida N, Tsuda E, Morinaga T, Higashio K and Ozawa H (1998) Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun 247: 610-615
30. Pawelec G, Adibzadeh M, Solana R and Beckman I (1997) The T cell in the ageing individual. Mech Ageing Dev 93: 35-45
31. Pawelec G, Barnett Y, Forsey R, Frasca D, Globerson A, McLeod J, Caruso C, Franceschi C, Fülöp T, Gupta S, Mariani E, Mocchegiani E and Solana R (2002) T cells and aging, January 2002 update. Front Biosci 7: d1056-d1183
32. Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ and Weyand CM (1993) Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 36: 1286-1294
33. Rogers A, Saleh G, Hannon RA, Greenfield D and Eastell R (2002) Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. J Clin Endocrinol Metab 87: 4470-4475
34. Roodman GD (1992) Interleukin-6: an osteotropic factor? J Bone Miner Res 7: 475-478
35. Salvarani C, Macchioni P, Zizzi F, Mantovani W, Rossi F, Castri C, Capozzoli N, Baricchi R, Boiardi L, Chiaravalloti F and Portioli I (1991) Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in Northern Italy. Arthritis Rheum 34: 351-356
36. Salvarani C, Macchioni P, Boiardi L, Rossi F, Casadei Maldini M, Mancini R, Beltrandi E, Spacca C, Lodi L and Portioli I (1992) Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations. J Rheumatol 19: 1100-1106
37. Salvarani C, Boiardi L, Macchioni P, Casadei Maldini M, Mancini R, Beltrandi E, Rossi F and Portioli I (1994) Serum soluble CD4 and CD8 levels in polymyalgia rheumatica. J Rheumatol 21: 1865-1869
38. Salvarani C, Cantini F, Boiardi L and Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 347: 261-271
39. Schoppet M, Preissner KT and Hofbauer LC (2002) RANK ligand and osteoprotegerin. Paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol 22: 549-553
40. Shiba H, Nakanishi K, Sakata M, Fujita T, Uchida Y and Kurihara H (2000) Effects of ageing on proliferative ability, and the expressions of secreted protein, acidic and rich in cysteine (SPARC) and osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human periodontal ligament cells. Mech Ageing Dev 117: 69-77
41. Szulc P, Hofbauer LC, Heufelder AE, Roth S and Delmas PD (2001) Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab 86: 3162-3165
42. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, et al. (1993) Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 90: 11924-11928
43. Theill LE, Boyle WJ and Penninger JM (2002) RANK-L and RANK: T cells, bone loss, and mammalian evolution. Ann Rev Immunol 20: 795-823